1 March 2018
LexaGene appoints Jeffrey Mitchell as Chief Financial Officer of the Company. Mr. Mitchell has over two decades of financial and SEC experience.
22 February 2018
LexaGene honored as a Top 50-Ranked TSX Venture company, ranked by share price, trading volume and market capitalization.
6 February 2018
LexaGene leases larger space to support company growth. The Company has significantly expanded its operations and made key new hires.